American Journal of Bioethics 11 (12):21-25 (2011)

Abstract
When prostate-specific antigen (PSA) testing was introduced, proponents expected it to cut prostate-cancer mortality and did not expect it to unleash an epidemic of unnecessary treatments. Now that evidence of a mortality benefit remains unclear while evidence of overtreatment in undeniable, there is understandable interest in reducing the human costs of the PSA system. Two related drugs, finasteride and dutasteride, both proven to reduce the incidence of prostate cancer and the ?risk of diagnosis,? are being promoted accordingly. However, if not for the flaws of the PSA system the use of these drugs for purposes of prevention would lose its rationale. Not only are the drugs in this sense dependent on a faulty system, but their own mortality benefits are as speculative as PSA's?in addition to which, they introduce new risks.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1080/15265161.2011.623932
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 59,916
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Prostate Cancer Prevention: Do the 5-ARIs Make the Grade?Howard L. Parnes - 2011 - American Journal of Bioethics 11 (12):30-31.

Add more citations

Similar books and articles

Personalized Cancer Care in an Age of Anxiety.Susan Gilbert - 2010 - Hastings Center Report 40 (5):18-21.
Prostate Cancer Prevention: Do the 5-ARIs Make the Grade?Howard L. Parnes - 2011 - American Journal of Bioethics 11 (12):30-31.
Justice and Lung Cancer.Aaron Wilson - 2013 - Journal of Medicine and Philosophy 38 (2):219-234.
Ethical Questions in the Age of the New Eugenics.Neil I. Wiener & David L. Wiesenthal - 1999 - Science and Engineering Ethics 5 (3):383-394.
Handbook of Clinical Neurology.P. Vinken & G. Bruyn (eds.) - 1969 - North Holland.

Analytics

Added to PP index
2011-12-07

Total views
21 ( #502,471 of 2,433,209 )

Recent downloads (6 months)
1 ( #463,180 of 2,433,209 )

How can I increase my downloads?

Downloads

My notes